Drugs / KHK4577
last change Dec 2014 re-read 3 minutes ago

KHK4577

Developed for
atopic eczema
Investigated by
Kyowa Kirin, Inc.

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02004119 Nov 2013 → Dec 2014 atopic eczema Kyowa Kirin, Inc. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as KHK4577 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02004119 ↗
Route Oral “oral KHK4577” NCT02004119 ↗